Lantus Solostar is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Sanofi-aventis U.s. Llc. The primary component is Insulin Glargine.
| Product ID | 0088-5020_2c27943b-b9d7-4838-8b39-618aab8b54fa |
| NDC | 0088-5020 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lantus Solostar |
| Generic Name | Insulin Glargine |
| Dosage Form | Injection, Solution |
| Route of Administration | SUBCUTANEOUS |
| Marketing Start Date | 2017-06-04 |
| Marketing Category | BLA / NDA |
| Application Number | BLA021081 |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | INSULIN GLARGINE |
| Active Ingredient Strength | 100 [iU]/mL |
| Pharm Classes | Insulin [Chemical/Ingredient],Insulin Analog [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2017-06-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA021081 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-06-04 |
| Marketing Category | BLA |
| Application Number | BLA021081 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2017-06-04 |
| Ingredient | Strength |
|---|---|
| INSULIN GLARGINE | 100 [iU]/mL |
| SPL SET ID: | 6328c99d-d75f-43ef-b19e-7e71f91e57f6 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0088-2219 | Lantus Solostar | insulin glargine |
| 70518-1390 | Lantus Solostar | Lantus Solostar |
| 0088-5020 | Lantus Solostar | Lantus Solostar |
| 50090-1398 | Lantus Solostar | Lantus Solostar |
| 0002-7715 | BASAGLAR | Insulin glargine |
| 0002-8214 | BASAGLAR | Insulin glargine |
| 0088-2220 | Lantus | insulin glargine |
| 0024-5869 | TOUJEO | insulin glargine |
| 0024-5871 | TOUJEO Max | insulin glargine |